Why Are These Five Stocks In Spotlight Today?
U.S. equities inched up on Monday after fresh data displayed that consumer spending rose marginally in February.
Acadia Pharmaceuticals Inc (ACAD)
Market is closed
News
- First
- << Previous
- 61 - 70
- Next >>
Healthcare-focused Baker Bros. Advisors' Top Picks: Incyte, Alexion, ACADIA & More
Baker Bros. Advisors is a New York City-based fund launched in 2000 by Julian and Felix Baker.
Top 5 Healthcare Bets of World-Class Baker Bros. Advisors
Baker Bros. Advisors is one of the most famous healthcare-focused equity hedge funds in the world today. It was founded in 2000 by brothers Julian Baker and Felix Baker in New York. Baker Bros.
ACADIA Pharmaceuticals Inc. (ACAD): Are Hedge Funds Right About This Stock?
Out of thousands of stocks that are currently traded on the market, it is difficult to determine those that can really generate strong returns.
Why Are These Four Stocks Making A Late Surge?
Shareholders of Amicus Therapeutics, Inc. (NASDAQ:FOLD), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Novavax, Inc.
Superconductor Technologies, Inc. (SCON), Pfizer Inc. (PFE), ACADIA Pharmaceuticals Inc. (ACAD): Sabby Capital's Latest Moves in Healthcare Sector
Hal Mintz's Sabby Capital has initiated a passive stake in Superconductor Technologies, Inc. (NASDAQ:SCON) according to a schedule 13G form filed with the SEC.
ACADIA Pharmaceuticals Inc. (ACAD), Pfizer Inc. (PFE): Sabby Management Rewarded for Its Healthcare Picks
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) spiked nearly 18% during Tuesday's intraday trading and hit a 52-week high of $46.48.
Newfield Exploration Co. (NFX), ACADIA Pharmaceuticals Inc. (ACAD): How Did Andreas Halvorsen's Small-Cap Picks Perform in Q3?
Andreas Halvorsen's Viking Global is a fund with great returns over its 15-years old history. Since its foundation, Viking's flagship fund returned on average 19% per year.
Triumph Group Inc (TGI), Intercept Pharmaceuticals Inc (ICPT), Zynga Inc (ZNGA): Viking Global’s Top 5 Small-Cap Picks
Small-cap picks from individual funds might provide investors with attractive investment options.
Baker Bros. Advisors' Latest Moves Involve ACADIA Pharmaceuticals Inc. (ACAD) & Synageva Biopharma Corp (TRMS)
Julian Baker and Felix Baker’s hedge fund, Baker Bros. Advisors, has recently tweaked its holdings in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) and Synageva Biopharma Corp (NASDAQ:TRMS).
- First
- << Previous
- 61 - 70
- Next >>
Billionaire Hedge Funds
